Page last updated: 2024-11-02

pentobarbital and Atrophy

pentobarbital has been researched along with Atrophy in 1 studies

Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.

Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
WAGNER, JW1
DE GROOT, J1

Other Studies

1 other study available for pentobarbital and Atrophy

ArticleYear
Changes in feeding behavior after intracerebral injections in the rat.
    The American journal of physiology, 1963, Volume: 204

    Topics: Acetylcholine; Animals; Appetite; Atrophy; Epinephrine; Feeding Behavior; Gallamine Triethiodide; Gl

1963